Literature DB >> 16337923

Targeting the HIV-1 RNA leader sequence with synthetic oligonucleotides and siRNA: chemistry and cell delivery.

John J Turner1, Martin Fabani, Andrey A Arzumanov, Gabriela Ivanova, Michael J Gait.   

Abstract

New candidates for development as potential drugs or virucides against HIV-1 infection and AIDS continue to be needed. The HIV-1 RNA leader sequence has many essential functional sites for virus replication and regulation that includes several highly conserved sequences. The review describes the historical context of targeting the HIV-1 RNA leader sequence with antisense phosphorothioate oligonucleotides, such as GEM 91, and goes on to describe modern approaches to targeting this region with steric blocking oligonucleotide analogues having newer and more advantageous chemistries, as well as recent studies on siRNA, towards the attainment of antiviral activity. Recent attempts to obtain improved cell delivery are highlighted, including exciting new developments in the use of peptide conjugates of peptide nucleic acid (PNA) as potential virucides.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16337923     DOI: 10.1016/j.bbamem.2005.10.013

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  13 in total

1.  DNA duplexes with hydrophobic modifications inhibit fusion between HIV-1 and cell membranes.

Authors:  Liang Xu; Lifeng Cai; Xueliang Chen; Xifeng Jiang; Huihui Chong; Baohua Zheng; Kun Wang; Junlin He; Wei Chen; Tao Zhang; Maosheng Cheng; Yuxian He; Keliang Liu
Journal:  Antimicrob Agents Chemother       Date:  2013-07-29       Impact factor: 5.191

Review 2.  Advances in targeting nucleocapsid-nucleic acid interactions in HIV-1 therapy.

Authors:  Divita Garg; Bruce E Torbett
Journal:  Virus Res       Date:  2014-07-12       Impact factor: 3.303

Review 3.  Targeting HIV transcription: the quest for a functional cure.

Authors:  Guillaume Mousseau; Sonia Mediouni; Susana T Valente
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

4.  HIV-1 drug discovery: targeting folded RNA structures with branched peptides.

Authors:  Jessica E Wynn; Webster L Santos
Journal:  Org Biomol Chem       Date:  2015-06-07       Impact factor: 3.876

5.  Carrier-free cellular uptake and the gene-silencing activity of the lipophilic siRNAs is strongly affected by the length of the linker between siRNA and lipophilic group.

Authors:  Natalya S Petrova; Ivan V Chernikov; Mariya I Meschaninova; Iiya S Dovydenko; Aliya G Venyaminova; Marina A Zenkova; Valentin V Vlassov; Elena L Chernolovskaya
Journal:  Nucleic Acids Res       Date:  2011-11-10       Impact factor: 16.971

6.  The HIV oligonucleotide database (HIVoligoDB).

Authors:  João Carneiro; Adriana Resende; Filipe Pereira
Journal:  Database (Oxford)       Date:  2017-01-01       Impact factor: 3.451

7.  Inhibition of 5'-UTR RNA conformational switching in HIV-1 using antisense PNAs.

Authors:  Braham Parkash; Atul Ranjan; Vinod Tiwari; Sharad Kumar Gupta; Navrinder Kaur; Vibha Tandon
Journal:  PLoS One       Date:  2012-11-12       Impact factor: 3.240

8.  A versatile method for the preparation of conjugates of peptides with DNA/PNA/analog by employing chemo-selective click reaction in water.

Authors:  Khirud Gogoi; Meenakshi V Mane; Sunita S Kunte; Vaijayanti A Kumar
Journal:  Nucleic Acids Res       Date:  2007-11-02       Impact factor: 16.971

9.  Efficient inhibition of HIV-1 expression by LNA modified antisense oligonucleotides and DNAzymes targeted to functionally selected binding sites.

Authors:  Martin R Jakobsen; Joost Haasnoot; Jesper Wengel; Ben Berkhout; Jørgen Kjems
Journal:  Retrovirology       Date:  2007-04-26       Impact factor: 4.602

10.  Strategies to Block HIV Transcription: Focus on Small Molecule Tat Inhibitors.

Authors:  Guillaume Mousseau; Susana Valente
Journal:  Biology (Basel)       Date:  2012-11-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.